Bill Sutherland Analyst PerformanceAnalyst at Cross ResearchBill Sutherland is a stock analyst at Cross Research focused in the medical sector, covering 16 publicly traded companies. Over the past year, Bill Sutherland has issued 23 stock ratings, including buy and hold recommendations. While full access to Bill Sutherland's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Bill Sutherland's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings49 Last 8 YearsBuy Recommendations95.83% 46 Buy RatingsCompanies Covered16 Unique Companies Ratings Distribution48RatingsDistribution of strong buy, buy, hold, and sell ratings by Bill Sutherland.RatingPercentageCount Strong Buy0.0%0 ratings Buy95.8%46 ratings Hold4.2%2 ratings Sell0.0%0 ratingsOut of 48 total stock ratings issued by Bill Sutherland at Cross Research, the majority (95.8%) have been Buy recommendations, followed by 4.2% Hold.Best & Worst CallsBest Call000.0%AMEDOct 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ATIPAug 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ62.5% of companies on NASDAQ10 companiesNYSE31.3% of companies on NYSE5 companiesNYSEAMERICAN6.3% of companies on NYSEAMERICAN1 companyBill Sutherland, an analyst at Cross Research, currently covers 16 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical10 companies62.5%Business Services5 companies31.3%Finance1 company6.3%Bill Sutherland of Cross Research specializes in stock coverage within the Medical sector, with additional focus on Business Services and Finance companies.Coverage IndustriesIndustryPercentageMEDICAL SERVICES4 companies25.0%STAFFING2 companies12.5%MEDICAL INFO SYS2 companies12.5%BUSINESS SVCS1 company6.3%REIT - EQTY TRUST - OTHER1 company6.3%MED - HMO1 company6.3%CONSULTING1 company6.3%MED PRODUCTS1 company6.3%NURSING & PERSONAL CARE FACILITIES1 company6.3%MED - OUTP/HM CRE1 company6.3%ADVERTISING/MKTG SVCS1 company6.3% Bill Sutherland's Ratings History at Cross Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsHCSGHealthcare Services Group4/23/2026Boost Price Target$22.89$30.00Buy$0.0000.00% ROIRCMTRCM Technologies4/8/2026Boost Price Target$27.20$36.00Buy$0.0000.00% ROIAGLAgilon Health4/2/2026Boost Price Target$10.27$13.00Buy$0.0000.00% ROICXWCoreCivic3/24/2026Initiated Coverage$20.24$28.00Buy$0.0000.00% ROIOMCLOmnicell3/13/2026Reiterated Rating$35.05Buy$0.0000.00% ROICCRNCross Country Healthcare3/5/2026Set Price Target$9.70$14.00$0.0000.00% ROICCRNCross Country Healthcare3/5/2026Upgrade$9.13$14.00Buy$0.0000.00% ROISEMSelect Medical3/4/2026Downgrade$16.25Hold$0.0000.00% ROISGRYSurgery Partners3/3/2026Reiterated Rating$13.16Buy$0.0000.00% ROIHCSGHealthcare Services Group2/12/2026Reiterated Rating$21.59Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. OMCLOmnicell2/2/2026Boost Price Target$48.50$60.00Buy$0.0000.00% ROIHURNHuron Consulting Group12/24/2025Boost Price Target$179.96$215.00Buy$0.0000.00% ROIBEATHeartBeam12/11/2025Reiterated Rating$1.54Speculative Buy$0.0000.00% ROIOMCLOmnicell12/9/2025Boost Price Target$43.55$50.00Buy$0.0000.00% ROISGRYSurgery Partners11/11/2025Lower Price Target$16.03$30.00Buy$0.0000.00% ROIOMCLOmnicell10/31/2025Boost Price Target$33.52$45.00Buy$0.0000.00% ROIHURNHuron Consulting Group10/27/2025Boost Price Target$154.17$180.00Buy$0.0000.00% ROIHCSGHealthcare Services Group10/23/2025Boost Price Target$18.85$24.00Buy$0.0000.00% ROIAGLAgilon Health8/6/2025Lower Price Target$23.30$37.50Buy$0.0000.00% ROIHCSGHealthcare Services Group7/24/2025Boost Price Target$14.05$19.00Buy$0.0000.00% ROINUTXNutex Health5/15/2025Boost Price Target$171.57$300.00Buy$0.0000.00% ROIQIPTQuipt Home Medical5/14/2025Reiterated Rating$1.64$4.00Buy$0.0000.00% ROIOMCLOmnicell5/7/2025Lower Price Target$24.75$40.00Buy$0.0000.00% ROISGRYSurgery Partners4/21/2025Reiterated Rating$20.31$35.00Buy$00.0000.00% ROIHURNHuron Consulting Group3/26/2025Reiterated Rating$144.12$165.00Buy$000.0000.00% ROIRCMTRCM Technologies3/21/2025Lower Price Target$15.67$30.00Buy$00.0000.00% ROIHURNHuron Consulting Group2/26/2025Boost Price Target$152.53$165.00Buy$000.0000.00% ROIOMCLOmnicell2/4/2025Reiterated Rating$43.60$62.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerRaymond James FinancialStifel NicolausBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
